Enrolment completed and recommended phase II dose reached for OXC-101 October 14, 2022 · Press releases Read article
New studies show OXC-101 further improves conventional chemotherapy treatment in Acute Myelom Leukemia (AML) March 23, 2022 · Press releases Read article
Oxcia reports positive interim data from clinical phase I study in advanced solid cancers January 17, 2022 · Press releases Read article
Oxcia contracts Patheon for manufacturing and further strengthens the organization · Press releases Read article
